Skip to content

Patients Suffering From Emotional Dysregulation

Retrospective Study of the Acceptability and Effectiveness of a Dialectical Behavioral Therapy Group in Patients Suffering From Emotional Dysregulation (Borderline Personality Disorder, Bipolar Disorder and Adult ADHD)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06616337
Acronym
Dys-Emotion
Enrollment
100
Registered
2024-09-27
Start date
2023-11-21
Completion date
2025-01-21
Last updated
2024-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emotional Dysregulation

Keywords

Emotional Dysregulation, Schizophrenia, Bipolar disorder, Borderline personality disorder, Attention deficit hyperactivity disorder (ADHD)

Brief summary

Emotional dysregulation (ED) is a common syndrome in psychiatric disorders. It is characterized by intense emotions, easily triggered, and with significant psychological impact: explosions of anger, irritability, impulsivity, emotional lability, etc. It is systematic in borderline personality disorder, and observed in a majority of patients with bipolar disorder. (even in the interictal period), adult ADHD, or addictions. ED is a cause of psychological distress, suicidal behavior or non-suicidal self-injury, and impaired quality of life. Pharmacological treatments only very partially improve these symptoms. Psychotherapies aimed at reducing ED are poorly developed in France. Dialectical behavioral therapy is a therapy that has shown its effectiveness in ED of BPD. This is why the psychiatry and addiction center of the University Hospitals of Strasbourg has set up groups using this psychotherapeutic approach based on this technique for almost 3 years. This technique being very little practiced in France, and even less studied, we want to see if it is adapted to a French population not accustomed to this type of practice.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Major subject (≥18 years old) * Having participated in the first session of a GREMO group, which is a behavioral and dialectical therapy protocol from January 1, 2018 to December 31, 2023, * Subject not opposing the reuse of their data for scientific research purposes.

Exclusion criteria

* Subject having expressed their opposition to the reuse of their personal data for scientific research purposes.

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the change of symptoms of emotional dysregulationUp to 1 year* The assessment is based on the DERS scale. Participants are asked to indicate how often the items apply to themselves, with responses ranging from 1 to 5, * The score between : * 1 means almost never (0 to 10%), * 2 means sometimes (11 to 35%), * 3 means about half the time (36 to 65%), * 4 means most of the time (66 to 90%), * 5 means almost always (91 to 100%).

Countries

France

Contacts

Primary ContactSébastien WEIBEL, MD
sebastien.weibel@chru-strasbourg.fr33 3 88 11 51 57

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026